03721nam a22005055i 4500001001800000003000900018005001700027007001500044008004100059020001800100024003500118050001700153072001600170072002300186072001600209100007600225245014900301250001800450264006900468300004500537336002600582337002600608338003600634347002400670490005700694505029500751520163601046650003602682650003502718650001602753650002002769650002902789650002802818650002302846650002602869650002002895650002902915710003402944773002602978776003603004776003603040776003603076830005703112856004603169978-3-031-63985-2DE-He21320251030112654.0cr nn 008mamaa240727s2024    sz |    s    |||| 0|eng d  a97830316398527 a10.1007/978-3-031-63985-22doi 4aRA971-971.85 7aKCQ2bicssc 7aBUS0701702bisacsh 7aKCVJ2thema1 aCandio, Paolo.eauthor.4aut4http://id.loc.gov/vocabulary/relators/aut10aSustainability and Corporate Performance in Health Careh[electronic resource] :bESG Implications for the European Industry /cby Paolo Candio.  a1st ed. 2024. 1aCham :bSpringer Nature Switzerland :bImprint: Springer,c2024.  aXVII, 134 p. 40 illus.bonline resource.  atextbtxt2rdacontent  acomputerbc2rdamedia  aonline resourcebcr2rdacarrier  atext filebPDF2rda1 aCSR, Sustainability, Ethics & Governance,x2196-70830 aSocial and Normative Context of Sustainability -- Sustainability in Health Care -- Normative and market instruments of sustainability -- Evolution of ESG and Corporate Performance in Health Care -- ESG and Economic Performance in Health Care -- ESG and Information Asymmetry in Health Care.  aThis book explores the multifaceted relationship between sustainability and corporate performance in health care by providing a review of the relevant policy and academic literature, together with novel quantitative evidence to support strategic and managerial decision-making. The book uniquely investigates whether and how improvements in sustainability-related activities and reporting, and respective ESG scores assigned by international rating agencies, are related to corporations’ economic and market performance. The potential development and expansion in private health care services and products, accelerated by the COVID-19 pandemic, calls for a new paradigm in the health care industry. After introducing the reader to the social and policy context for sustainable development and to various normative and market instruments used to assess sustainability and corporate performance, the book presents the results of statistical analyses conducted on a representative sample of top health care companies listed in European capital markets and draws conclusions about the profitability and effectiveness of sustainability- and ESG-related investments. There’s a current debate about whether investing in sustainability not only fulfills ethical obligations but also drives long-term value. The empirical literature often presents conflicting findings, particularly when it comes to scholars’ relatively limited evaluation of the health care industry. The book sheds new light on this proposition and offers guidance on sustainable decision-making in health care, making it relevant for researchers and professionals. 0aHealth services administration. 0aBusiness enterprisesxFinance. 0aAccounting. 0aSustainability. 0aIndustrial organization.14aHealth Care Management.24aCorporate Finance.24aFinancial Accounting.24aSustainability.24aIndustrial Organization.2 aSpringerLink (Online service)0 tSpringer Nature eBook08iPrinted edition:z978303163984508iPrinted edition:z978303163986908iPrinted edition:z9783031639876 0aCSR, Sustainability, Ethics & Governance,x2196-708340uhttps://doi.org/10.1007/978-3-031-63985-2